| 76.67 Data as of May 24 |  +0.15 / +0.20%Today’s Change | 44.92 Today|||52-Week Range 78.36 | +32.72% Year-to-Date |
| ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog May 13 / Zacks.com |
| Previous close | 76.52 |
| Today’s open | 76.09 |
| Day’s range | 75.42 - 76.99 |
| Volume | 196,751 |
| Average volume (3 months) | 383,562 |
| Market cap | $4.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -22.22% |
| Earnings growth (this year) | +16.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +5.78% |
| P/E ratio | 39.7 |
| Price/Sales | 1.34 |
| Price/Book | 3.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| CLDXCelldex Therapeutics... | +0.11 | +0.89% |
| MGMistras Group Inc | +0.31 | +1.48% |
| NEONeogenomics Inc | -0.18 | -4.76% |
| FCSCFibrocell Science In... | -0.05 | -1.03% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $94.7M |
| Net profit margin | 4.00% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman & Chief Executive Officer Joseph L. Herring |
Chief Financial Officer & Vice President Alison A. Cornell, MBA |
Corporate headquarters Princeton, New Jersey |
.
